Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Neurological Medicine
Volume 2015, Article ID 841897, 3 pages
http://dx.doi.org/10.1155/2015/841897
Case Report

Relapsing Remitting Multiple Sclerosis in X-Linked Charcot-Marie-Tooth Disease with Central Nervous System Involvement

Neurogenetics Unit, 1st Department of Neurology, University of Athens Medical School, Eginition Hospital, 74 Vasilissis Sophias Avenue, 11528 Athens, Greece

Received 13 February 2015; Accepted 18 March 2015

Academic Editor: Mathias Toft

Copyright © 2015 Georgios Koutsis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. A. Kleopa and S. S. Scherer, “Molecular genetics of X-linked charcot-marie-tooth disease,” NeuroMolecular Medicine, vol. 8, no. 1-2, pp. 107–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Panas, C. Karadimas, D. Avramopoulos, and D. Vassilopoulos, “Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 65, no. 6, pp. 947–948, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Panas, N. Kalfakis, C. Karadimas, and D. Vassilopoulos, “Episodes of generalized weakness in two sibs with the C164T mutation of the connexin 32 gene,” Neurology, vol. 57, no. 10, pp. 1906–1908, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. H. L. Paulson, J. Y. Garbern, T. F. Hoban et al., “Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease,” Annals of Neurology, vol. 52, no. 4, pp. 429–434, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Isoardo, N. Di Vito, M. Nobile, G. Benetton, and F. Fassio, “X-linked Charcot-Marie-Tooth disease and progressive-relapsing central demyelinating disease,” Neurology, vol. 65, no. 10, pp. 1672–1673, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Parman, F. Ciftci, M. Poyraz et al., “X-linked Charcot-Marie-Tooth disease and multiple sclerosis,” Journal of Neurology, vol. 254, no. 7, pp. 953–955, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Karadima, G. Koutsis, M. Raftopoulou, P. Floroskufi, K.-M. Karletidi, and M. Panas, “Four novel connexin 32 mutations in X-linked Charcot-Marie-Tooth disease. Phenotypic variability and central nervous system involvement,” Journal of the Neurological Sciences, vol. 341, no. 1-2, pp. 158–161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. C. H. Polman, S. C. Reingold, B. Banwell et al., “Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria,” Annals of Neurology, vol. 69, no. 2, pp. 292–302, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Ginsberg, O. Malik, A. R. Kenton et al., “Coexistent hereditary and inflammatory neuropathy,” Brain, vol. 127, no. 1, pp. 193–202, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Sallusto, D. Impellizzieri, C. Basso et al., “T-cell trafficking in the central nervous system,” Immunological Reviews, vol. 248, no. 1, pp. 216–227, 2012. View at Publisher · View at Google Scholar · View at Scopus